GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a remarkable shift in how we treat diabetes mellitus . These new therapies function to stimulating the body’s own GLP-1 substance , which https://bookmark-media.com/story21824287/glp-1-a-significant-breakthrough-in-glucose-treatment